Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms

Status unconfirmed · Phase 3

Conditions studied: Raynaud Disease

In brief

The purpose of this study is to determine if Vascana, a novel topical formulation of nitroglycerin, is effective in the treatment and prevention of the symptoms associated with Raynaud's Phenomenon.

Key facts

Study ID
NCT00934427
Run by
MediQuest Therapeutics
People needed
100
Starts
2009-06-01
Expected to finish
2010-07-01
Last updated by the study team
2010-07-20

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.